Action SAVA CASSAVA SCIENCES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Cassava Sciences, Inc.

Actions

SAVA

US14817C1071

Temps réel estimé Cboe BZX
Autres places de cotation
 17:11:35 05/06/2024 		Varia. 5j. Varia. 1 janv.
20,94 USD -0,48 % Graphique intraday de Cassava Sciences, Inc. -1,13 % -6,53 %
17/05 CASSAVA SCIENCES, INC. : HC Wainwright persiste à l'achat ZM
10/05 Cassava Sciences, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
AQ
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
GL
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
GL
Cassava Sciences : Warrants – Notice of Guaranteed Delivery
PU
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
GL
Cassava Sciences : Corporate Presentation – Second Quarter 2024
PU
Cassava Sciences, Inc. - Redemption Date Announced for Warrants
AQ
Redemption Date Announced for Warrants
GL
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
PR
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR
Cassava Sciences : Corporate Presentation – First Quarter 2024
PU
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
GL
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
PR
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
PR
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
NE
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
NE
ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
NE
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SAVA
  4. Actualités Cassava Sciences, Inc.
  5. Communiqués
-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT